Of Mice, Macaques, and Men: Broadly Neutralizing Antibody Immunotherapy for HIV-1

被引：58

作者：

Nishimura, Yoshiaki ^{[1
]}

Martin, Malcolm A. ^{[1
]}

机构：

[1] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA

来源：

CELL HOST & MICROBE | 2017年 / 22卷 / 02期

基金：

美国国家卫生研究院;

关键词：

IMMUNODEFICIENCY-VIRUS; POTENT NEUTRALIZATION; MONOCLONAL-ANTIBODIES; IMPROVES PROTECTION; IMMUNE-RESPONSES; INFECTION; THERAPY; RESERVOIR; VRC01; IDENTIFICATION;

D O I：

10.1016/j.chom.2017.07.010

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The neutralizing antibodies targeting the HIV-1 envelope protein have been a major focus for HIV therapy. Early studies with anti-HIV-1 neutralizing monoclonal antibodies (mAbs) administered to infected individuals showed some promise, as they resulted in transient reductions in plasma viremia in some recipients. However, resistant viral variants rapidly emerged. A major development during the past 6 to 7 years has been the isolation and characterization of highly potent and broadly neutralizing mAbs (bNAbs) from infected individuals known as "elite neutralizers." These "next-generation" bNAbs have been tested in animal model systems and shown to effectively control virus replication, particularly following combination immunotherapy. The success of these preclinical animal studies has led to human clinical trials using an individual bNAb for therapy. This review examines recent findings from animal models and human clinical trials and discusses the future use of bNAbs for HIV-1 treatment.

引用

页码：207 / 216

页数：10

共 57 条

[1] Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption [J].

Bar, K. J. ;

Sneller, M. C. ;

Harrison, L. J. ;

Justement, J. S. ;

Overton, E. T. ;

Petrone, M. E. ;

Salantes, D. B. ;

Seamon, C. A. ;

Scheinfeld, B. ;

Kwan, R. W. ;

Learn, G. H. ;

Proschan, M. A. ;

Kreider, E. F. ;

Blazkova, J. ;

Bardsley, M. ;

Refsland, E. W. ;

Messer, M. ;

Clarridge, K. E. ;

Tustin, N. B. ;

Madden, P. J. ;

Oden, K. S. ;

O'Dell, S. J. ;

Jarocki, B. ;

Shiakolas, A. R. ;

Tressler, R. L. ;

Doria-Rose, N. A. ;

Bailer, R. T. ;

Ledgerwood, J. E. ;

Capparelli, E. V. ;

Lynch, R. M. ;

Graham, B. S. ;

Moir, S. ;

Koup, R. A. ;

Mascola, J. R. ;

Hoxie, J. A. ;

Fauci, A. S. ;

Tebas, P. ;

Chun, T-W .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (21) :2037-2050

[2] Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys [J].

Barouch, Dan H. ;

Whitney, James B. ;

Moldt, Brian ;

Klein, Florian ;

Oliveira, Thiago Y. ;

Liu, Jinyan ;

Stephenson, Kathryn E. ;

Chang, Hui-Wen ;

Shekhar, Karthik ;

Gupta, Sanjana ;

Nkolola, Joseph P. ;

Seaman, Michael S. ;

Smith, Kaitlin M. ;

Borducchi, Erica N. ;

Cabral, Crystal ;

Smith, Jeffrey Y. ;

Blackmore, Stephen ;

Sanisetty, Srisowmya ;

Perry, James R. ;

Beck, Matthew ;

Lewis, Mark G. ;

Rinaldi, William ;

Chakraborty, Arup K. ;

Poignard, Pascal ;

Nussenzweig, Michel C. ;

Burton, Dennis R. .

NATURE, 2013, 503 (7475) :224-+

[3] New Approaches to Antiretroviral Drug Delivery: Challenges and Opportunities Associated with the Use of Long-Acting Injectable Agents [J].

Boffito, Marta ;

Jackson, Akil ;

Owen, Andrew ;

Becker, Stephen .

DRUGS, 2014, 74 (01) :7-13

[4] Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs [J].

Bolton, Diane L. ;

Pegu, Amarendra ;

Wang, Keyun ;

McGinnis, Kathleen ;

Nason, Martha ;

Foulds, Kathryn ;

Letukas, Valerie ;

Schmidt, Stephen D. ;

Chen, Xuejun ;

Todd, John Paul ;

Lifson, Jeffrey D. ;

Rao, Srinivas ;

Michael, Nelson L. ;

Robb, Merlin L. ;

Mascola, John R. ;

Koup, Richard A. .

JOURNAL OF VIROLOGY, 2016, 90 (03) :1321-1332

[5] Antibody-virus co-evolution in HIV infection: paths for HIV vaccine development [J].

Bonsignori, Mattia ;

Liao, Hua-Xin ;

Gao, Feng ;

Williams, Wilton B. ;

Alam, S. Munir ;

Montefiori, David C. ;

Haynes, Barton F. .

IMMUNOLOGICAL REVIEWS, 2017, 275 (01) :145-160

[6] Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity [J].

Bournazos, Stylianos ;

Klein, Florian ;

Pietzsch, John ;

Seaman, Michael S. ;

Nussenzweig, Michel C. ;

Ravetch, Jeffrey V. .

CELL, 2014, 158 (06) :1243-1253

[7] Parameters for establishing humanized mouse models to study human immunity: Analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rγnull mutation [J].

Brehm, Michael A. ;

Cuthbert, Amy ;

Yang, Chaoxing ;

Miller, David M. ;

Dilorio, Philip ;

Laning, Joseph ;

Burzenski, Lisa ;

Gott, Bruce ;

Foreman, Oded ;

Kavirayani, Anoop ;

Herlihy, Mary ;

Rossini, Aldo A. ;

Shultz, Leonard D. ;

Greiner, Dale L. .

CLINICAL IMMUNOLOGY, 2010, 135 (01) :84-98

[8] Antibody responses to envelope glycoproteins in HIV-1 infection [J].

Burton, Dennis R. ;

Mascola, John R. .

NATURE IMMUNOLOGY, 2015, 16 (06) :571-576

[9] EFFICIENT NEUTRALIZATION OF PRIMARY ISOLATES OF HIV-1 BY A RECOMBINANT HUMAN MONOCLONAL-ANTIBODY [J].

BURTON, DR ;

PYATI, J ;

KODURI, R ;

SHARP, SJ ;

THORNTON, GB ;

PARREN, PWHI ;

SAWYER, LSW ;

HENDRY, RM ;

DUNLOP, N ;

NARA, PL ;

LAMACCHIA, M ;

GARRATTY, E ;

STIEHM, ER ;

BRYSON, YJ ;

CAO, YZ ;

MOORE, JP ;

HO, DD ;

BARBAS, CF .

SCIENCE, 1994, 266 (5187) :1024-1027

[10] Long-Term Antiretroviral Treatment Initiated at Primary HIV-1 Infection Affects the Size, Composition, and Decay Kinetics of the Reservoir of HIV-1-Infected CD4 T Cells [J].

Buzon, Maria J. ;

Martin-Gayo, Enrique ;

Pereyra, Florencia ;

Ouyang, Zhengyu ;

Sun, Hong ;

Li, Jonathan Z. ;

Piovoso, Michael ;

Shaw, Amy ;

Dalmau, Judith ;

Zangger, Nadine ;

Martinez-Picado, Javier ;

Zurakowski, Ryan ;

Yu, Xu G. ;

Telenti, Amalio ;

Walker, Bruce D. ;

Rosenberg, Eric S. ;

Lichterfeld, Mathias .

JOURNAL OF VIROLOGY, 2014, 88 (17) :10056-10065

← 1 2 3 4 5 6 →